About the Authors
- Sherry T. Hikita
-
Affiliations Center for Stem Cell Biology and Engineering, University of California Santa Barbara, Santa Barbara, California, United States of America, Department of Molecular, Cellular and Developmental Biology, University of California Santa Barbara, Santa Barbara, California, United States of America
- Kenneth S. Kosik
-
Affiliations Center for Stem Cell Biology and Engineering, University of California Santa Barbara, Santa Barbara, California, United States of America, Department of Molecular, Cellular and Developmental Biology, University of California Santa Barbara, Santa Barbara, California, United States of America, Neuroscience Research Institute, University of California Santa Barbara, Santa Barbara, California, United States of America
- Dennis O. Clegg
-
Affiliations Center for Stem Cell Biology and Engineering, University of California Santa Barbara, Santa Barbara, California, United States of America, Department of Molecular, Cellular and Developmental Biology, University of California Santa Barbara, Santa Barbara, California, United States of America, Neuroscience Research Institute, University of California Santa Barbara, Santa Barbara, California, United States of America
- Cynthia Bamdad
-
* E-mail: cbamdad@minervabio.com
Affiliation Minerva Biotechnologies, Waltham, Massachusetts, United States of America
Competing Interests
Drs. Kosik and Bamdad are shareholders in Minerva Biotechnologies.
Author Contributions
Conceived and designed the experiments: KSK CCB. Performed the experiments: STH. Analyzed the data: STH KSK DC CCB. Contributed reagents/materials/analysis tools: CCB. Wrote the paper: CCB. Sole or lead inventor on the novel target MUC1*, antibodies and methods to manipulate cancer and stem cell growth by manipulating the MUC1* receptor: CCB.